Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Blog - Page 83

Blog

Relief Therapeutics reported that NRx Pharma announced additional results from Aviptadil expanded access protocol for patients with COVID-19
COVID-19 | Life Science History

Relief Therapeutics reported that NRx Pharma announced additional results from Aviptadil expanded access protocol for patients with COVID-19

On Jun. 16, 2021, RELIEF THERAPEUTICS reported that its collaboration partner, NRx Pharmaceuticals, had announced additional results from…

Read More Relief Therapeutics reported that NRx Pharma announced additional results from Aviptadil expanded access protocol for patients with COVID-19Continue

RECOVERY trial found Regeneron’s monoclonal antibody combination reduced deaths for hospitalised COVID-19 patients
Biotechnology | COVID-19 | Disease | Medicine

RECOVERY trial found Regeneron’s monoclonal antibody combination reduced deaths for hospitalised COVID-19 patients

On Jun. 16, 2021, the University of Oxford announced the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial demonstrated…

Read More RECOVERY trial found Regeneron’s monoclonal antibody combination reduced deaths for hospitalised COVID-19 patientsContinue

U.S. Government purchased additional 200 million doses of Moderna’s COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

U.S. Government purchased additional 200 million doses of Moderna’s COVID-19 vaccine

On Jun. 16, 2021, Moderna announced that the U.S. government had purchased an additional 200 million doses of…

Read More U.S. Government purchased additional 200 million doses of Moderna’s COVID-19 vaccineContinue

REGEN-COV phase 3 RECOVERY trial met primary outcome, improving survival in Hospitalized COVID-19 patients
Biotechnology | COVID-19 | Disease | Therapeutics | Vaccine

REGEN-COV phase 3 RECOVERY trial met primary outcome, improving survival in Hospitalized COVID-19 patients

On Jun. 16, 2021, Regeneron announced positive results from the largest trial assessing any monoclonal antibody treatment in…

Read More REGEN-COV phase 3 RECOVERY trial met primary outcome, improving survival in Hospitalized COVID-19 patientsContinue

Data published in NEJM showed Pfizer’s Tofacitinib met primary endpoint in Brazilian study in patients with COVID-19 pneumonia
Biotechnology | COVID-19 | Disease | Vaccine

Data published in NEJM showed Pfizer’s Tofacitinib met primary endpoint in Brazilian study in patients with COVID-19 pneumonia

On Jun. 16, 2021, Pfizer and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein announced…

Read More Data published in NEJM showed Pfizer’s Tofacitinib met primary endpoint in Brazilian study in patients with COVID-19 pneumoniaContinue

KPWHRI announced volunteers needed for COVID-19 vaccine-booster trial
Biotechnology | COVID-19 | Infectious Disease | NIH | Vaccine

KPWHRI announced volunteers needed for COVID-19 vaccine-booster trial

On Jun. 16, 2021, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that was recruiting volunteers in the…

Read More KPWHRI announced volunteers needed for COVID-19 vaccine-booster trialContinue

Oncotelic closes COVID-19 clinical trial early
COVID-19 | Life Science History

Oncotelic closes COVID-19 clinical trial early

On Jun. 15, 2021, Oncotelic announced that, as of June 11, 2021, it discontinued enrollment in its OT-101…

Read More Oncotelic closes COVID-19 clinical trial earlyContinue

Moderna and Magenta partner to distribute Moderna’s COVID-19 vaccine in United Arab Emirates
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Moderna and Magenta partner to distribute Moderna’s COVID-19 vaccine in United Arab Emirates

On Jun. 15, 2021, Moderna and Magenta Investments, an industrial conglomerate in the United Arab Emirates (UAE), announced…

Read More Moderna and Magenta partner to distribute Moderna’s COVID-19 vaccine in United Arab EmiratesContinue

University of British Columbia researchers received the New Frontiers in Research Fund 2020 Exploration award
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

University of British Columbia researchers received the New Frontiers in Research Fund 2020 Exploration award

On Jun. 14, 2021, University of British Columbia researchers Dr. Jayachandran Kizhakkedathu, Dr. Caigan Du and Dr. Christopher…

Read More University of British Columbia researchers received the New Frontiers in Research Fund 2020 Exploration awardContinue

Humanigen initiated submission for lenzilumab Marketing Authorization in COVID-19, to United Kingdomメs MHRA
Life Science History

Humanigen initiated submission for lenzilumab Marketing Authorization in COVID-19, to United Kingdomメs MHRA

On Jun. 14, 2021 Humanigen announced it had initiated a rolling review submission for Marketing Authorization (MA) by…

Read More Humanigen initiated submission for lenzilumab Marketing Authorization in COVID-19, to United Kingdomメs MHRAContinue

Moderna submitted authorization application for its COVID-19 vaccine in adolescents in Switzerland
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna submitted authorization application for its COVID-19 vaccine in adolescents in Switzerland

On Jun. 14, 2021, Moderna announced that it had submitted an authorization application to Swissmedic for use of…

Read More Moderna submitted authorization application for its COVID-19 vaccine in adolescents in SwitzerlandContinue

Novavax COVID-19 vaccine demonstrated 90% overall efficacy and 100% protection in phase 3 trial
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax COVID-19 vaccine demonstrated 90% overall efficacy and 100% protection in phase 3 trial

On Jun. 14, 2021, Novavax announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against…

Read More Novavax COVID-19 vaccine demonstrated 90% overall efficacy and 100% protection in phase 3 trialContinue

Novavax announced positive results from study of influenza vaccine and COVID-19 vaccine candidate administered simultaneously
Biotechnology | Infectious Disease | Influenza | Vaccine

Novavax announced positive results from study of influenza vaccine and COVID-19 vaccine candidate administered simultaneously

On Jun. 14, 2021, Novavax announced data from the first co-administration study of a SARS-CoV-2 vaccine candidate [Novavax,…

Read More Novavax announced positive results from study of influenza vaccine and COVID-19 vaccine candidate administered simultaneouslyContinue

Cocrystal’s COVID-19 antiviral CDI-45205 shown to be active against SARS-CoV-2 and prominent SARS-CoV-2 variants
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

Cocrystal’s COVID-19 antiviral CDI-45205 shown to be active against SARS-CoV-2 and prominent SARS-CoV-2 variants

On Jun. 14, 2021, Cocrystal Pharma announced the selection of CDI-45205 as the lead compound for further development…

Read More Cocrystal’s COVID-19 antiviral CDI-45205 shown to be active against SARS-CoV-2 and prominent SARS-CoV-2 variantsContinue

G7 announced pledges of 870 million COVID-19 vaccine doses
COVID-19 | Life Science History | Vaccine

G7 announced pledges of 870 million COVID-19 vaccine doses

On Jun. 13, 2021, G7 global leaders pledged to share COVID-19 vaccine doses internationally, in support of global…

Read More G7 announced pledges of 870 million COVID-19 vaccine dosesContinue

Emergent BioSolutions’ COVID-19 vaccine drug substance authorized as part of Johnson & Johnson EUA
COVID-19 | FDA | Life Science History

Emergent BioSolutions’ COVID-19 vaccine drug substance authorized as part of Johnson & Johnson EUA

On Jun. 11, 2021, Emergent BioSolutions announced that two batches of COVID-19 vaccine manufactured by at its Baltimore…

Read More Emergent BioSolutions’ COVID-19 vaccine drug substance authorized as part of Johnson & Johnson EUAContinue

Quidel received amended Emergency Use Authorization for new Sofia Q rapid antigen test device
Biotechnology | FDA

Quidel received amended Emergency Use Authorization for new Sofia Q rapid antigen test device

On Jun. 11, 2021, Quidel announced it had received an amended Emergency Use Authorization (EUA) from the U.S….

Read More Quidel received amended Emergency Use Authorization for new Sofia Q rapid antigen test deviceContinue

Moderna and Tabuk Pharmaceuticals partnered to commercialize  COVID-19 Vaccine in Saudi Arabia
Biotechnology | COVID-19 | Therapeutics | Vaccine

Moderna and Tabuk Pharmaceuticals partnered to commercialize COVID-19 Vaccine in Saudi Arabia

On Jun. 11, 2021, Moderna and Tabuk Pharmaceutical announced an agreement to commercialize the Moderna COVID-19 Vaccine and…

Read More Moderna and Tabuk Pharmaceuticals partnered to commercialize COVID-19 Vaccine in Saudi ArabiaContinue

FDA issued EUA for the Janssen COVID-19 vaccine manufactured at Emergent BioSolutions facility in Baltimore
COVID-19 | FDA | Life Science History

FDA issued EUA for the Janssen COVID-19 vaccine manufactured at Emergent BioSolutions facility in Baltimore

On Jun. 11, 2021, The FDA issued an emergency use authorization (EUA) for the Janssen COVID-19 vaccine, two…

Read More FDA issued EUA for the Janssen COVID-19 vaccine manufactured at Emergent BioSolutions facility in BaltimoreContinue

Novavax announces positive data from three complementary studies of COVID-19 Beta variant strain vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax announces positive data from three complementary studies of COVID-19 Beta variant strain vaccine

On Jun. 11, 2021, Novavax announced preclinical and clinical data on the company’s original recombinant protein COVID-19 vaccine…

Read More Novavax announces positive data from three complementary studies of COVID-19 Beta variant strain vaccineContinue

Novan announced positive ppreclinical data in SB019 COVID-19 anti-viral therapy program
COVID-19 | Life Science History

Novan announced positive ppreclinical data in SB019 COVID-19 anti-viral therapy program

On Jun. 10, 2021, Novan announced positive preclinical results with berdazimer sodium in a SARS-CoV-2 transmission model in…

Read More Novan announced positive ppreclinical data in SB019 COVID-19 anti-viral therapy programContinue

Moderna filed for Emergency Use Authorization for its COVID-19 vaccine in adolescents in the United States
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna filed for Emergency Use Authorization for its COVID-19 vaccine in adolescents in the United States

On Jun. 10, 2021, Moderna announced that it had requested an emergency use authorization (EUA) for its COVID-19…

Read More Moderna filed for Emergency Use Authorization for its COVID-19 vaccine in adolescents in the United StatesContinue

Pfizer and BioNTech provided 500 million doses of COVID-19 vaccine to U.S. Government for donation to poorest nations
COVID-19 | Life Science History | Vaccine

Pfizer and BioNTech provided 500 million doses of COVID-19 vaccine to U.S. Government for donation to poorest nations

On Jun. 10, 2021, Pfizer and BioNTech announced plans to provide the U.S. government at a not-for-profit price…

Read More Pfizer and BioNTech provided 500 million doses of COVID-19 vaccine to U.S. Government for donation to poorest nationsContinue

Vertex announces FDA approval for TRIKAFTAᆴ in children with Cystic Fibrosis ages 6 through 11 with certain mutations
FDA | Life Science History

Vertex announces FDA approval for TRIKAFTAᆴ in children with Cystic Fibrosis ages 6 through 11 with certain mutations

On Jun. 9, 2021, Vertex Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approved expanded use of…

Read More Vertex announces FDA approval for TRIKAFTAᆴ in children with Cystic Fibrosis ages 6 through 11 with certain mutationsContinue

Roche obtained CE mark for SARS-CoV-2 antigen self test nasal allowing for rapid self testing of COVID-19 at home
Life Science History

Roche obtained CE mark for SARS-CoV-2 antigen self test nasal allowing for rapid self testing of COVID-19 at home

On Jun. 8, 2021, Roche announced it had received CE mark for its SARS-CoV-2 Antigen Self Test Nasal…

Read More Roche obtained CE mark for SARS-CoV-2 antigen self test nasal allowing for rapid self testing of COVID-19 at homeContinue

Merck announced supply agreement with U.S. Government for molnupiravir, an Investigational oral antiviral treatment of COVID-19
COVID-19 | Life Science History

Merck announced supply agreement with U.S. Government for molnupiravir, an Investigational oral antiviral treatment of COVID-19

On Jun. 8, 2021, Merck announced it had entered into a procurement agreement with the U.S. government for…

Read More Merck announced supply agreement with U.S. Government for molnupiravir, an Investigational oral antiviral treatment of COVID-19Continue

RECOVERY trial found aspirin does not improve survival for patients hospitalised with COVID-19
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Neurology | Pharmaceutical

RECOVERY trial found aspirin does not improve survival for patients hospitalised with COVID-19

On Jun. 8, 2021, the University of Oxford announced that the RECOVERY trial found aspirin does not improve…

Read More RECOVERY trial found aspirin does not improve survival for patients hospitalised with COVID-19Continue

Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variants
Biotechnology | COVID-19 | Diagnostics | Therapeutics | Vaccine

Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variants

On Jun. 8, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…

Read More Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variantsContinue

Senolytics reduced COVID-19 symptoms in preclinical studies
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Veterinary

Senolytics reduced COVID-19 symptoms in preclinical studies

On Jun. 8, 2021, Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates…

Read More Senolytics reduced COVID-19 symptoms in preclinical studiesContinue

Pixel by Labcorpᆴ COVID-19 PCR test home collection kits now available nationwide
COVID-19 | Life Science History

Pixel by Labcorpᆴ COVID-19 PCR test home collection kits now available nationwide

On Jun. 8, 2021, LabCorp announced that its Pixel COVID-19 PCR Test Home Collection Kits were availavle in…

Read More Pixel by Labcorpᆴ COVID-19 PCR test home collection kits now available nationwideContinue

Page navigation

Previous PagePrevious 1 … 81 82 83 84 85 … 346 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search